← Eichor
Study identifier: NCT07568223 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tolerance to an Artisanal Bread in a Population Intolerant of the Conventional Bread and Study of Associated Markers

Condition: Intolerance to "Conventional" Bread  ·  Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The objective of this study is to evaluate the effect of consuming an "artisanal" bread for 15 days on gastrointestinal symptoms in individuals intolerant to "conventional" bread. "Conventional bread" refers to bread made with refined wheat flour (ash = 0.55% of dry matter), containing gluten, and leavened with baker's yeast (Saccharomyces cerevisiae). "Artisanal bread" refers to bread made with whole wheat flour (ash = 1.50% of dry matter) from an ancient durum wheat variety (Russello) and leavened with sourdough.

This description comes directly from the study's public registry record.

Talk to the study team

Fabien Wuestenberghs  ·  +330148952276  ·  fabien.wuestenberghs@aphp.fr

Claire Gaudichon  ·  +33144081829  ·  claire.gaudichon@agroapristech.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Centre de Recherche sur VolontairesBobigny, FranceRecruiting
Centre de Recherche sur Volontaires (CRV)Bobigny, Île-de-France Region, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07568223